1 week Ago By Defense World Staff
Arrowstreet Capital Limited Partnership acquired a new stake in shares of Haleon plc ( NYSE:HLN – Free Report ) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 935,260 shares of the company’s stock, valued at approximately $8,922,000. Several other hedge funds and other institutional investors have also made changes to their positions in HLN.
Addison Advisors LLC boosted its holdings in Haleon by 28.7% during the 4th quarter. Addison Advisors LLC now owns 4,954 shares of the company’s stock valued at $47,000 after acquiring an additional 1,106 shares during the period.
Synovus Financial Corp boosted its stake in shares of Haleon by 0.8% during the third quarter. Synovus Financial Corp now owns 148,834 shares of the company’s stock valued at $1,575,000 after purchasing an additional 1,216 shares during the period.
Haverford Trust Co grew its holdings in shares of Haleon by 5.0% in the fourth quarter. Haverford Trust Co now owns 25,842 shares of the company’s stock worth $247,000 after purchasing an additional 1,233 shares during the last quarter.
Greenleaf Trust increased its stake in Haleon by 8.4% in the 4th quarter. Greenleaf Trust now owns 17,225 shares of the company’s stock worth $164,000 after buying an additional 1,333 shares during the period.
Finally, Baron Wealth Management LLC lifted its holdings in Haleon by 4.3% during the 4th quarter. Baron Wealth Management LLC now owns 33,632 shares of the company’s stock valued at $321,000 after buying an additional 1,381 shares in the last quarter.
Hedge funds and other institutional investors own 6.67% of the company’s stock. Analysts Set New Price Targets HLN has been the topic of a number of research analyst reports.
Sanford C. Bernstein downgraded shares of Haleon from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 8th. Morgan Stanley downgraded Haleon from an “overweight” rating to an “equal weight” rating in a report on Friday, January 10th.
Deutsche Bank Aktiengesellschaft reiterated a “hold” rating on shares of Haleon in a report on Monday, March 3rd. HSBC restated a “hold” rating on shares of Haleon in a research note on Wednesday, March 5th. Finally, Hsbc Global Res lowered shares of Haleon from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, March 5th.
Six research analysts have rated the stock with a hold rating, one has given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, Haleon presently has a consensus rating of “Hold” and an average price target of $10.
95. Haleon Stock Performance Shares of NYSE HLN opened at $9.89 on Monday.
The company has a 50 day simple moving average of $10.03 and a two-hundred day simple moving average of $9.86.
The stock has a market cap of $44.66 billion, a price-to-earnings ratio of 29.07, a PEG ratio of 2.
82 and a beta of 0.24. The company has a current ratio of 0.
84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44.
Haleon plc has a 12 month low of $7.99 and a 12 month high of $10.80.
Haleon ( NYSE:HLN – Get Free Report ) last posted its earnings results on Thursday, February 27th. The company reported $0.05 earnings per share (EPS) for the quarter.
The company had revenue of $3.54 billion during the quarter, compared to the consensus estimate of $3.38 billion.
Haleon had a net margin of 10.85% and a return on equity of 14.76%.
As a group, analysts predict that Haleon plc will post 0.43 earnings per share for the current year. Haleon Increases Dividend The business also recently announced a — dividend, which will be paid on Thursday, June 5th.
Investors of record on Friday, April 25th will be issued a dividend of $0.1166 per share. This represents a yield of 1.
6%. This is a positive change from Haleon’s previous — dividend of $0.05.
The ex-dividend date of this dividend is Friday, April 25th. Haleon’s dividend payout ratio (DPR) is 58.97%.
About Haleon ( Free Report ) Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. Featured Articles Five stocks we like better than Haleon Options Trading – Understanding Strike Price Newsmax’s IPO Whiplash: Meme Stock Hype or Growth Potential? Expert Stock Trading Psychology Tips Disney 2025 Shareholders: Major Updates for Investors How to Invest in Tech Stocks and Top Tech Stocks to Consider Advance Auto Parts Stock: A Classic Rebound Play in the Making Want to see what other hedge funds are holding HLN? Visit HoldingsChannel.
com to get the latest 13F filings and insider trades for Haleon plc ( NYSE:HLN – Free Report ). Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter .
.
